中/EN Contact/Message
Innovate
Amvuttra
Amvuttra
departments:内科
drug:注射剂
Active:vutrisiran
indication:治疗遗传性经甲状腺素介导的淀粉样变多发性神经病
Licensor:Alnylam
Approved Country/Region:FDA
Approval time:2022-06-13